AmeriFlex Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2
Closed -$587 – 1294
2026
Q2
$587 Buy
+2
New +$567 ﹤0.01% 1486
2026
Q1
– Sell
-19
Closed -$5.76K – 1122
2025
Q4
$5.76K Sell
19
-19
-50% -$5.93K ﹤0.01% 826
2025
Q3
$10.7K Buy
+38
New +$10.3K ﹤0.01% 766
2025
Q2
– Sell
-5
Closed -$1.22K – 1077
2025
Q1
$1.22K Hold
5
– – ﹤0.01% 1188
2024
Q4
$1.8K Buy
+5
New +$1.7K ﹤0.01% 1061

Other funds holding BIO

AmeriFlex Group's BIO Position: Q3 2026 in Review

AmeriFlex Group sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2026, closing a stake of 2 shares — an estimated $587 sold.

AmeriFlex Group first reported a position in BIO in Q4 2024 and held it in 5 quarters. The position peaked at $10.7K in Q3 2025. 380 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • AmeriFlex Group reported no remaining Bio-Rad Laboratories Class A position as of Q3 2026 after selling out during the quarter.
  • AmeriFlex Group sold 2 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $587.
  • AmeriFlex Group first reported a position in Bio-Rad Laboratories Class A in Q4 2024 and held it in 5 quarters.
  • AmeriFlex Group's Bio-Rad Laboratories Class A position peaked at $10.7K in Q3 2025.
  • 380 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on AmeriFlex Group's 13F filing for Q3 2026, filed 13 Nov 2026.